Corecivic Financials
This page shows Corecivic (CXW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025's higher earnings were funded by a less cash-efficient growth cycle as receivables and capex climbed together.
From FY2024 to FY2025, net income rose to$116.5M while free cash flow fell to$52.8M . The gap widened because accounts receivable swelled and capital spending doubled, which means more of the year's growth was tied up in customer collections and reinvestment instead of becoming immediately reusable cash.
The balance sheet looks liquid on the surface with a current ratio of 1.7x, but cash slipped to
After improving through FY2024, leverage turned back up in FY2025: long-term debt increased to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Corecivic's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Corecivic's revenue grew 12.7% year-over-year to $2.2B, a solid pace of expansion. This earns a growth score of 60/100.
Corecivic has a moderate D/E ratio of 0.86. This balance of debt and equity financing earns a leverage score of 50/100.
Corecivic's current ratio of 1.66 indicates adequate short-term liquidity, earning a score of 47/100. The company can meet its near-term obligations, though with limited headroom.
While Corecivic generated $194.6M in operating cash flow, capex of $141.8M consumed most of it, leaving $52.8M in free cash flow. This results in a low score of 52/100, reflecting heavy capital investment rather than weak cash generation.
Corecivic passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Corecivic generates $1.67 in operating cash flow ($194.6M OCF vs $116.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Corecivic generated $2.2B in revenue in fiscal year 2025. This represents an increase of 12.7% from the prior year.
Corecivic reported $116.5M in net income in fiscal year 2025. This represents an increase of 69.2% from the prior year.
Corecivic earned $1.08 per diluted share (EPS) in fiscal year 2025. This represents an increase of 74.2% from the prior year.
Cash & Balance Sheet
Corecivic generated $52.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 73.4% from the prior year.
Corecivic held $97.9M in cash against $1.2B in long-term debt as of fiscal year 2025.
Corecivic had 98M shares outstanding in fiscal year 2025. This represents a decrease of 10.2% from the prior year.
Margins & Returns
Corecivic's net profit margin was 5.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.8 percentage points from the prior year.
Corecivic's ROE was 8.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 3.7 percentage points from the prior year.
Capital Allocation
Corecivic spent $229.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 196.7% from the prior year.
Corecivic invested $141.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 101.4% from the prior year.
CXW Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $614.7M+1.8% | $604.0M+4.1% | $580.4M+7.9% | $538.2M+10.1% | $488.6M+1.9% | $479.3M-2.5% | $491.6M+0.3% | $490.1M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $43.7M-1.6% | $44.4M-2.0% | $45.3M+3.2% | $43.9M+21.8% | $36.0M-11.2% | $40.5M-1.5% | $41.2M+21.4% | $33.9M |
| Operating Income | $136.7M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $17.7M-0.8% | $17.8M+7.2% | $16.6M+32.6% | $12.5M-17.7% | $15.2M-3.0% | $15.7M-1.9% | $16.0M-6.5% | $17.1M |
| Income Tax | $14.4M+47.9% | $9.7M-5.1% | $10.3M-25.3% | $13.7M+96.6% | $7.0M+18.5% | $5.9M-35.2% | $9.1M+5.3% | $8.6M |
| Net Income | $37.9M+42.9% | $26.5M+0.9% | $26.3M-31.7% | $38.5M+53.5% | $25.1M+30.3% | $19.3M-8.6% | $21.1M+11.3% | $19.0M |
| EPS (Diluted) | $0.38 | N/A | $0.24-31.4% | $0.35+52.2% | $0.23 | N/A | $0.19+11.8% | $0.17 |
CXW Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.4B+3.4% | $3.3B+4.7% | $3.1B+1.3% | $3.1B+2.3% | $3.0B+2.4% | $2.9B+0.6% | $2.9B+0.4% | $2.9B |
| Current Assets | $743.5M+21.7% | $611.1M+29.6% | $471.6M-3.2% | $487.4M+17.9% | $413.5M-8.1% | $449.8M+8.1% | $416.1M+8.6% | $383.0M |
| Cash & Equivalents | $209.7M+114.1% | $97.9M+73.2% | $56.6M-56.7% | $130.5M+75.2% | $74.5M-30.7% | $107.5M-0.3% | $107.8M+79.2% | $60.2M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $479.8M+7.5% | $446.2M+27.0% | $351.4M+17.0% | $300.4M+6.5% | $282.1M-2.3% | $288.7M+9.0% | $264.8M-3.2% | $273.7M |
| Goodwill | $8.6M0.0% | $8.6M0.0% | $8.6M+76.5% | $4.8M0.0% | $4.8M0.0% | $4.8M0.0% | $4.8M0.0% | $4.8M |
| Total Liabilities | $2.0B+6.5% | $1.9B+12.9% | $1.6B+2.9% | $1.6B+4.4% | $1.5B+6.2% | $1.4B+0.1% | $1.4B-1.2% | $1.5B |
| Current Liabilities | $305.0M-17.3% | $368.9M+10.3% | $334.4M+10.0% | $304.0M+14.0% | $266.6M-6.7% | $285.8M+4.0% | $274.7M+3.1% | $266.5M |
| Long-Term Debt | $1.4B+14.6% | $1.2B+17.2% | $1.0B+2.2% | $1.0B+3.8% | $969.9M-0.3% | $973.1M-0.7% | $979.8M-2.7% | $1.0B |
| Total Equity | $1.4B-0.7% | $1.4B-4.4% | $1.5B-0.5% | $1.5B+0.2% | $1.5B-1.2% | $1.5B+1.2% | $1.5B+2.0% | $1.4B |
| Retained Earnings | -$85.6M+30.7% | -$123.5M+17.7% | -$150.0M+14.9% | -$176.3M+17.9% | -$214.9M+10.5% | -$240.0M+7.4% | -$259.3M+7.5% | -$280.4M |
CXW Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $13.8M+3762.2% | -$376K-100.7% | $53.8M-44.4% | $96.7M+117.4% | $44.5M+13.3% | $39.3M-57.1% | $91.5M+34.4% | $68.1M |
| Capital Expenditures | $20.7M-53.8% | $44.8M+18.8% | $37.7M+8.0% | $34.9M+42.1% | $24.5M+5.5% | $23.3M+30.5% | $17.8M-4.9% | $18.7M |
| Free Cash Flow | -$6.9M+84.7% | -$45.1M-380.1% | $16.1M-74.0% | $61.9M+209.9% | $20.0M+24.6% | $16.0M-78.3% | $73.7M+49.3% | $49.3M |
| Investing Cash Flow | -$22.8M+42.0% | -$39.3M+63.2% | -$106.7M-204.2% | -$35.1M-40.4% | -$25.0M-31.3% | -$19.0M-41.7% | -$13.4M+23.8% | -$17.6M |
| Financing Cash Flow | $120.9M+50.4% | $80.4M+540.3% | -$18.3M-176.3% | -$6.6M+87.7% | -$53.7M-242.0% | -$15.7M+44.3% | -$28.2M+72.4% | -$102.1M |
| Dividends Paid | N/A | $0 | $0-100.0% | $45K | $0 | $0 | $0-100.0% | $116K |
| Share Buybacks | $55.1M-42.1% | $95.1M+137.5% | $40.0M-7.5% | $43.3M-14.4% | $50.6M+531.3% | $8.0M | $0-100.0% | $20.2M |
CXW Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | 22.2% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | 6.2%+1.8pp | 4.4%-0.1pp | 4.5%-2.6pp | 7.2%+2.0pp | 5.1%+1.1pp | 4.0%-0.3pp | 4.3%+0.4pp | 3.9% |
| Return on Equity | 2.7%+0.8pp | 1.9%+0.1pp | 1.8%-0.8pp | 2.6%+0.9pp | 1.7%+0.4pp | 1.3%-0.1pp | 1.4%+0.1pp | 1.3% |
| Return on Assets | 1.1%+0.3pp | 0.8%-0.0pp | 0.9%-0.4pp | 1.3%+0.4pp | 0.8%+0.2pp | 0.7%-0.1pp | 0.7%+0.1pp | 0.7% |
| Current Ratio | 2.44+0.8 | 1.66+0.2 | 1.41-0.2 | 1.60+0.1 | 1.55-0.0 | 1.57+0.1 | 1.51+0.1 | 1.44 |
| Debt-to-Equity | 0.99+0.1 | 0.86+0.2 | 0.70+0.0 | 0.68+0.0 | 0.660.0 | 0.65-0.0 | 0.66-0.0 | 0.70 |
| FCF Margin | -1.1%+6.3pp | -7.5%-10.3pp | 2.8%-8.7pp | 11.5%+7.4pp | 4.1%+0.7pp | 3.3%-11.6pp | 15.0%+4.9pp | 10.1% |
Similar Companies
Frequently Asked Questions
What is Corecivic's annual revenue?
Corecivic (CXW) reported $2.2B in total revenue for fiscal year 2025. This represents a 12.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Corecivic's revenue growing?
Corecivic (CXW) revenue grew by 12.7% year-over-year, from $2.0B to $2.2B in fiscal year 2025.
Is Corecivic profitable?
Yes, Corecivic (CXW) reported a net income of $116.5M in fiscal year 2025, with a net profit margin of 5.3%.
How much debt does Corecivic have?
As of fiscal year 2025, Corecivic (CXW) had $97.9M in cash and equivalents against $1.2B in long-term debt.
What is Corecivic's net profit margin?
Corecivic (CXW) had a net profit margin of 5.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Corecivic's return on equity (ROE)?
Corecivic (CXW) has a return on equity of 8.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Corecivic's free cash flow?
Corecivic (CXW) generated $52.8M in free cash flow during fiscal year 2025. This represents a -73.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Corecivic's operating cash flow?
Corecivic (CXW) generated $194.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Corecivic's total assets?
Corecivic (CXW) had $3.3B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Corecivic's capital expenditures?
Corecivic (CXW) invested $141.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Corecivic's current ratio?
Corecivic (CXW) had a current ratio of 1.66 as of fiscal year 2025, which is generally considered healthy.
What is Corecivic's debt-to-equity ratio?
Corecivic (CXW) had a debt-to-equity ratio of 0.86 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Corecivic's return on assets (ROA)?
Corecivic (CXW) had a return on assets of 3.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Corecivic's Piotroski F-Score?
Corecivic (CXW) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Corecivic's earnings high quality?
Corecivic (CXW) has an earnings quality ratio of 1.67x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Corecivic?
Corecivic (CXW) scores 35 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.